| Product NDC: | 62646-798 |
| Proprietary Name: | Anticoagulant Sodium Citrate |
| Non Proprietary Name: | Sodium Citrate |
| Active Ingredient(s): | 10 g/250mL & nbsp; Sodium Citrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62646-798 |
| Labeler Name: | Medsep Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA760305 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110415 |
| Package NDC: | 62646-798-60 |
| Package Description: | 250 mL in 1 BAG (62646-798-60) |
| NDC Code | 62646-798-60 |
| Proprietary Name | Anticoagulant Sodium Citrate |
| Package Description | 250 mL in 1 BAG (62646-798-60) |
| Product NDC | 62646-798 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sodium Citrate |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110415 |
| Marketing Category Name | NDA |
| Labeler Name | Medsep Corporation |
| Substance Name | SODIUM CITRATE |
| Strength Number | 10 |
| Strength Unit | g/250mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |